Genetic and Pharmacological Inhibition of Dimethylarginine Dimethylaminohydrolase 1 Is Protective in Endotoxic Shock

Dimethylarginine Dimethylaminohydrolase-1 Is the Critical Enzyme for Degrading the Cardiovascular Risk Factor Asymmetrical Dimethylarginine

(2011) Xinli Hu et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

LKB1 is required for hepatic bile acid transport and canalicular membrane integrity in mice

(2011) Angela Woods et al.   BIOCHEMICAL JOURNAL

Dopamine versus norepinephrine in the treatment of septic shock

(2011) Daniel De Backer et al.   CRITICAL CARE MEDICINE

The therapeutic potential of targeting endogenous inhibitors of nitric oxide synthesis

(2011) James Leiper et al.   NATURE REVIEWS DRUG DISCOVERY

Vascular hyporesponsiveness to vasopressors in septic shock: from bench to bedside

(2010) B. Levy et al.   INTENSIVE CARE MEDICINE

Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research

(2010) Carol Kilkenny et al.   PLOS BIOLOGY

Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008

(2009) R Phillip Dellinger et al.   CRITICAL CARE MEDICINE

Immunodesign of experimental sepsis by cecal ligation and puncture

(2009) Daniel Rittirsch et al.   Nature Protocols

Over-expression of GTP-cyclohydrolase 1 feedback regulatory protein attenuates LPS and cytokine-stimulated nitric oxide production

(2008) Manasi Nandi et al.   VASCULAR MEDICINE